FR2319362A1 - Medicament a base de substances possedant le squelette de l'eburnane - Google Patents

Medicament a base de substances possedant le squelette de l'eburnane

Info

Publication number
FR2319362A1
FR2319362A1 FR7523983A FR7523983A FR2319362A1 FR 2319362 A1 FR2319362 A1 FR 2319362A1 FR 7523983 A FR7523983 A FR 7523983A FR 7523983 A FR7523983 A FR 7523983A FR 2319362 A1 FR2319362 A1 FR 2319362A1
Authority
FR
France
Prior art keywords
compsn
amides
esters
theophylline
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7523983A
Other languages
English (en)
Other versions
FR2319362B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parcor SARL
Original Assignee
Parcor SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parcor SARL filed Critical Parcor SARL
Priority to FR7523983A priority Critical patent/FR2319362A1/fr
Publication of FR2319362A1 publication Critical patent/FR2319362A1/fr
Application granted granted Critical
Publication of FR2319362B1 publication Critical patent/FR2319362B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7523983A 1975-07-31 1975-07-31 Medicament a base de substances possedant le squelette de l'eburnane Granted FR2319362A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7523983A FR2319362A1 (fr) 1975-07-31 1975-07-31 Medicament a base de substances possedant le squelette de l'eburnane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7523983A FR2319362A1 (fr) 1975-07-31 1975-07-31 Medicament a base de substances possedant le squelette de l'eburnane

Publications (2)

Publication Number Publication Date
FR2319362A1 true FR2319362A1 (fr) 1977-02-25
FR2319362B1 FR2319362B1 (fr) 1978-07-07

Family

ID=9158620

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7523983A Granted FR2319362A1 (fr) 1975-07-31 1975-07-31 Medicament a base de substances possedant le squelette de l'eburnane

Country Status (1)

Country Link
FR (1) FR2319362A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032113A1 (fr) * 1995-04-12 1996-10-17 Decox, S.L. Nouvelle composition stimulatrice de l'activite cerebrale, a base d'alcaloides du type a noyau d'eburnamenine, et procedes de preparation
EP2320896A2 (fr) * 2008-07-03 2011-05-18 Osteogenex Inc. Dérivés de la vinpocétine et de l'éburnamonine favorisant la croissance osseuse

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996032113A1 (fr) * 1995-04-12 1996-10-17 Decox, S.L. Nouvelle composition stimulatrice de l'activite cerebrale, a base d'alcaloides du type a noyau d'eburnamenine, et procedes de preparation
ES2097703A1 (es) * 1995-04-12 1997-04-01 Decox S A Una nueva composicion estimulante de la actividad cerebral basada en alcaloides de nucleo de eburnamenina, y sus metodos de preparacion.
EA000189B1 (ru) * 1995-04-12 1998-12-24 Декокс, С.Л. Композиция на основе алкалоидов эбурнаменинового типа, стимулирующая церебральную активность
AU719877B2 (en) * 1995-04-12 2000-05-18 Covex Farma S.L. A new composition which stimulates cerebral activity, based upon alkaloids with an eburnamenine nucleus, and methods for their preparation
US6290994B1 (en) 1995-04-12 2001-09-18 Decox, S.L. Beverage containing caffeine or theobromine and vinpocetine citrate for stimulating cerebral activity
EP2320896A2 (fr) * 2008-07-03 2011-05-18 Osteogenex Inc. Dérivés de la vinpocétine et de l'éburnamonine favorisant la croissance osseuse
EP2320896A4 (fr) * 2008-07-03 2012-08-29 Osteogenex Inc Dérivés de la vinpocétine et de l'éburnamonine favorisant la croissance osseuse

Also Published As

Publication number Publication date
FR2319362B1 (fr) 1978-07-07

Similar Documents

Publication Publication Date Title
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
SE8403487D0 (sv) Farmaceutisk komposition
ATE89755T1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
GR76810B (fr)
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
ES2010561A6 (es) Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina.
EP0214254A1 (fr) Compositions de melatonine et leurs utilisations.
ZA763155B (en) Improvements in or relating to compounds having a physiological action on the nervous system of the human body and compositions containing them
ATE51343T1 (de) Abwaschbare topische zubereitung zur therapie der psoriasis.
DE68926115T2 (de) Verfahren zur behandlung von akne
EP0285856A3 (en) Use of dihydroergotamine and its salts in the local treatment of trophic disorders
FR2319362A1 (fr) Medicament a base de substances possedant le squelette de l'eburnane
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
NO175885C (no) Fremgangsmåte for fremstilling av et salicylsyreholdig middel for lokal behandling av hudsykdommer med avskalling
IT1199972B (it) Composizioni farmaceutiche per la terapia di sindromi cerebrali involutive e del decadimento mentale
Zangwill Neurological studies and human behaviour.
AT298664B (de) Verfahren zur Herstellung von Leitschienen aus menschlichen oder tierischen Geweben zur Wiederherstellung beschädigter oder zerstörter spezifischer Gewebsteile im menschlichen und tierischen Körper
GB980436A (en) The acid salt composed of acetyl glutamic acid and n,n-dimethylaminoethanol-1 and preparation of same
PH12038A (en) Composition containing cyclobenzaprine for use in the treatment of skeletal muscle disorders and method of treatmen
Silverman " Therapeutic value of laughter": Commentary.
GR3001209T3 (en) 4-methoxy-isophthalic acid derivative having a pharmacological activity in thromboembolic disorders and a process for the preparation thereof
DE3865531D1 (de) Aktive substanz in der kardiovaskulaeren therapie.
DE3476736D1 (en) Use of an antihypoxidoticum with cerebral and peripheral effect
FR2269948A1 (en) Antiparkinsonism compsn contg ergot alkaloid - and a phosphodiesterase inhibitor for longer or more intense effect

Legal Events

Date Code Title Description
ST Notification of lapse